共 603 条
[1]
Badar T(2015)Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade Am J Hematol 90 1065-1070
[2]
Kantarjian HM(2008)Acute GvHD: pathogenesis and classification Bone Marrow Transplant 41 S58-S64
[3]
Nogueras-Gonzalez GM(2007)Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML Blood 109 2264-2265
[4]
Borthakur G(2009)A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML Blood 113 4063-4073
[5]
Garcia Manero G(2009)Nomenclature evolution: changes in the ISCN from the 2005 to the 2009 edition Cytogenetic and Genome Research 127 1-4
[6]
Andreeff M(2012)Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis J Clin Oncol 30 735-741
[7]
Konopleva M(2012)Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm–combined prospective analysis by the German AML Intergroup J Clin Oncol 30 3604-3610
[8]
Kadia TM(2013)Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia N Engl J Med 368 2059-2074
[9]
Daver N(2012)Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning Bone Marrow Transplant 47 1171-1177
[10]
Wierda WG(2016)A phase I study of quizartinib combined with chemotherapy in relapsed childhood leukemia: a therapeutic advances in childhood leukemia & lymphoma (TACL) study Clin Cancer Res 22 4014-4022